Variant report
Variant | nsv613144 |
---|---|
Chromosome Location | chr9:3061261-3120123 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:62477919..62478756-chr9:3062250..3062792,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73391587 | chr9:3062008-3062009 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550167477 | chr9:3062011-3062012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369282003 | chr9:3062054-3062055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570368428 | chr9:3062066-3062067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539387741 | chr9:3062089-3062090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs7041084 | chr9:3062092-3062093 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs572713909 | chr9:3062106-3062107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534687558 | chr9:3062118-3062119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554673269 | chr9:3062127-3062128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189149791 | chr9:3062153-3062154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192538244 | chr9:3062169-3062170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563387338 | chr9:3062171-3062172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs56020201 | chr9:3062185-3062186 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs140426644 | chr9:3062189-3062190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs145648943 | chr9:3062190-3062191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181017705 | chr9:3070659-3070660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568440880 | chr9:3070690-3070691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534409611 | chr9:3070716-3070717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs554120281 | chr9:3070724-3070725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573773535 | chr9:3070727-3070728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs76505451 | chr9:3070753-3070754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554326092 | chr9:3070756-3070757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs34667647 | chr9:3070808-3070809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573035606 | chr9:3070817-3070818 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575426816 | chr9:3070838-3070839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147133949 | chr9:3070881-3070882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185080310 | chr9:3070894-3070895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558889831 | chr9:3070895-3070896 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368289613 | chr9:3070911-3070912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565195940 | chr9:3070922-3070923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs116370101 | chr9:3070942-3070943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138025567 | chr9:3070965-3070966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560781231 | chr9:3071010-3071011 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs543844086 | chr9:3071041-3071042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs56105985 | chr9:3071085-3071086 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs560963705 | chr9:3071155-3071156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188377444 | chr9:3071184-3071185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568876665 | chr9:3071190-3071191 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs146988831 | chr9:3073414-3073415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs3904472 | chr9:3073429-3073430 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs559932844 | chr9:3073430-3073431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs3904471 | chr9:3073433-3073434 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs137960016 | chr9:3073446-3073447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574053368 | chr9:3073463-3073464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs75211308 | chr9:3073493-3073494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539844071 | chr9:3073536-3073537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35599643 | chr9:3073630-3073631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536658633 | chr9:3073631-3073632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557842381 | chr9:3073644-3073645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185540829 | chr9:3073668-3073669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 16715143 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 21373258 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Ovarian cancer | 22355333 | CNVD |
Autism | 20808228 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:3062000-3062200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr9:3070600-3071200 | Weak transcription | Primary monocytes fromperipheralblood | blood |
3 | chr9:3073400-3074800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr9:3073400-3074800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr9:3074000-3074600 | Enhancers | Primary monocytes fromperipheralblood | blood |
6 | chr9:3074000-3074800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr9:3074200-3074600 | Enhancers | H9 Cell Line | embryonic stem cell |
8 | chr9:3074400-3074800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr9:3080400-3080800 | Enhancers | Primary hematopoietic stem cells | blood |
10 | chr9:3087600-3088800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr9:3087600-3088800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr9:3088000-3088400 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr9:3088000-3088800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
14 | chr9:3088800-3090000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
15 | chr9:3090000-3090200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr9:3099000-3100800 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
17 | chr9:3099000-3100800 | Enhancers | Fetal Brain Male | brain |
18 | chr9:3099200-3100400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
19 | chr9:3099600-3100200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr9:3099800-3100200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
21 | chr9:3110200-3110400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
22 | chr9:3111000-3111200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
23 | chr9:3118000-3118400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
24 | chr9:3118800-3119800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |